Conversion Rate of Tuberculosis Screening Tests among Dermatology Patients Treated with Tumor Necrosis Factor Inhibitors

BACKGROUND: The use of tumor necrosis factor-α inhibitors (TNFi) has been associated with an increased risk latent tuberculosis (TB) reactivation. The role of TB screening assays in monitoring patients during TNFi therapy remains uncertain. Spontaneous conversions and reversions have been described....

Descripción completa

Detalles Bibliográficos
Autores principales: Alsukait, Sarah F, Alsaad, Alaa B, Alotaibi, Ghadah F, Alsaif, Fahad M, Alotaibi, Hend M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154160/
https://www.ncbi.nlm.nih.gov/pubmed/35656235
http://dx.doi.org/10.4103/ijd.ijd_201_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154160/
https://www.ncbi.nlm.nih.gov/pubmed/35656235
http://dx.doi.org/10.4103/ijd.ijd_201_21

Ejemplares similares